News

Multiple new members have voiced anti-vaccine views that are not based in scientific evidence. Their actions could shape the ...
Robert Malone has just been appointed by Robert F. Kennedy Jr. as a member of the ACIP Vaccine Advisory Committee. In response he tweeted: "Thank you for the honor of serving my country in this way, ...
Novavax's COVID-19-influenza vaccines show strong immune response in older adults, paving the way for regulatory approval.
Three years after litigation started over technology used in an mRNA vaccine for COVID-19, Biontech SE is acquiring its ...
German biotech firm BioNTech has agreed to acquire domestic peer CureVac for about $1.25 billion worth of BioNTech shares, it ...
BioNTech's $1.25 billion acquisition of CureVac creates a "German biotech champion" focused on mRNA-based cancer treatments, with CureVac shares surging 38% on the announcement.
BioNTech said Thursday it has agreed to acquire smaller biotech CureVac in a $1.25 billion all-stock deal in another push to ...
Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, the companies said Thursday, bringing together two ...
BioNTech is buying fellow German mRNA vaccine developer CureVac in all-stock transaction that values the acquired biotech at ...
BioNTech said Thursday it would buy CureVac, its onetime competitor in the Covid-19 vaccine race, for about $1.25 billion in ...
By Ludwig Burger (Reuters) -German biotech firm BioNTech has agreed to acquire domestic peer CureVac for about $1.25 billion ...
CureVac (CVAC) stock jumps as BioNTech (BNTX) agrees to acquire in an all-stock deal worth $1.25B. Read more here.